Mohamed Ghareeb
Cairo, C, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
BCR-ABL1 Transcript ≤10% IS an Early Molecular Response Predictor of Treatment-Free Remission Eligibility in Chronic Myeloid Leukemia.
Journal: Clinical lymphoma, myeloma & leukemia
Published: January 28, 2026
The influence of lymphoid enhancer binding factor-1 expression on the outcome of adult acute promyelocytic leukemia patients.
Journal: Expert review of hematology
Published: February 17, 2025
Clinical significance of EVI-1 gene expression and aberrations in patient with de-novo acute myeloid and acute lymphoid leukemia.
Journal: Leukemia research
Published: November 17, 2022
Estrogen Receptor Gene Polymorphism as a Possible Genetic Risk Factor for Treatment Response in ER-Positive Breast Cancer Patients.
Journal: Biochemical genetics
Published: June 29, 2021
Crosstalk between liver-related microRNAs and Wnt/β-catenin pathway in hepatocellular carcinoma patients.
Journal: Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology
Published: July 04, 2017
Circulating DNA in Egyptian Women with Breast Cancer.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: July 01, 2016
Human myeloid inhibitory C-lectin: a highly specific and stable acute myeloid leukemia marker.
Journal: Hematological oncology
Published: April 15, 2016
Prevalence of the frequency of JAK2 (V617F) mutation in different myeloproliferative disorders in Egyptian patients.
Journal: International journal of clinical and experimental pathology
Published: July 25, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026